Daxor (NASDAQ: DXR - Get Free Report) and RadNet (NASDAQ: RDNT - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Volatility and Risk Daxor has a beta of 0.01, indicating
LOS ANGELES, Feb. 17, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its fourth quarter 2025 financial results on Monday, March 2, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
LOS ANGELES, Feb. 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of digital health solutions, announced today that it has acquired the outpatient imaging assets of Northwest Radiology Network, P.C., marking the company's entry into Indiana and expanding RadNet's presence into the Midwestern United States.
WCM Investment Management LLC lifted its position in RadNet, Inc. (NASDAQ: RDNT) by 32.6% in the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 285,778 shares of the medical research company's stock after acquiring an additional 70,244 shares during the period. WCM Investment Management LLC
New York State Common Retirement Fund decreased its stake in RadNet, Inc. (NASDAQ: RDNT) by 5.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 247,479 shares of the medical research company's stock after selling 13,532 shares during the quarter.
/PRNewswire/ -- USANewsGroup.com News Commentary - The global medical imaging market hit a massive $45.5 billion in 2026[1], marking a total structural shift
Emerald Advisers LLC trimmed its position in RadNet, Inc. (NASDAQ: RDNT) by 4.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 642,167 shares of the medical research company's stock after selling 30,189 shares during the quarter. RadNet comprises 1.6% of Emerald
New York State Teachers Retirement System grew its holdings in RadNet, Inc. (NASDAQ: RDNT) by 53.1% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 30,855 shares of the medical research company's stock after acquiring an additional 10,700 shares during the
RadNet, Inc. (RDNT) Presents at 44th Annual J.P. Morgan Healthcare Conference Prepared Remarks Transcript
LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer, Dr. Gregory Sorensen, Executive Vice President and Chief Strategy Officer and Kees Wesdorp, President & CEO of RadNet Digital Health will be presenting at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 10:30 a.m. PST.
